Skip to main navigation
Skip to search
Skip to main content
the University of Groningen research portal Home
Help & FAQ
English
Nederlands
Home
Profiles
Research units
Research output
Activities
Datasets
Press/Media
Projects
Prizes
Search by expertise, name or affiliation
Revertant cell therapy for epidermolysis bullosa
Antoni Gostynski
Research output
:
Thesis
›
Thesis fully internal (DIV)
2583
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Revertant cell therapy for epidermolysis bullosa'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Blister
12%
Butterfly
25%
Cell Therapy
100%
Current Therapeutics
12%
Epidermolysis Bullosa
100%
Fragile Skin
37%
Healthy Skin
25%
Induced Pluripotent Stem Cells (iPSCs)
12%
Inherited Skin Disease
12%
Laminin 332
12%
Long-term Survival
12%
Mouse Model
12%
Mucosa
12%
Natural Gene Therapy
12%
Revertant
100%
Revertant Mosaicism
25%
Skin Area
25%
Skin Biopsy
12%
Skin Cells
37%
Skin Graft
25%
Therapeutic Approaches
12%
Type XVII Collagen
12%
Medicine and Dentistry
Cell Therapy
100%
Collagen Type 17
10%
Dermatosis
10%
Disease
10%
Epidermolysis bullosa
100%
Gene Therapy
10%
Induced Pluripotent Stem Cell
10%
Kalinin
10%
Long Term Survival
10%
Mosaicism
20%
Mucosa
10%
Revertant
100%
Skin Biopsy
10%
Skin Cell
30%
Skin Graft
20%
Transplantation
10%
Immunology and Microbiology
Induced Pluripotent Stem Cell
10%
Laminin
10%
Long Term Survival
10%
Mosaicism
20%
Mouse Model
10%
Mucosa
10%
Revertant
100%
Skin Cell
30%
Transplant Procedure
10%